Ftse Mib
34.603,61
0,00%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.866,08
-0,38%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito AQSE Apollon Formularies plc (APOL) Apollon Formularies plc (APOL) Notizie

APOL

Apollon Formularies (APOL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AQSE:APOL
DataOraFonteTitoloSimboloCompagnia
03/05/202413:59UK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
01/05/202416:00UK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
20/02/202411:59UK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
02/01/202409:18UK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
05/12/202312:59UK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
21/11/202312:51UK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
29/09/202308:00UK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
19/09/202310:18UK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
03/08/202311:51UK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
02/08/202313:19UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
24/07/202312:00UK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
30/06/202318:32UK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
11/04/202315:00UK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
21/03/202313:00UK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
15/03/202308:00UK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
12/01/202308:00UK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
30/12/202213:37UK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
02/12/202208:00UK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
30/09/202210:50UK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
13/09/202208:02UK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
02/08/202210:11UK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
26/07/202208:00UK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
30/06/202217:29UK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
30/06/202213:33UK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
17/06/202214:23UK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
05/05/202213:07UK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
02/03/202208:01UK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
09/02/202208:00UK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
03/02/202207:59UK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
27/01/202208:00UK RegulatoryApollon Formularies plc Chief Science Officer Appointed as Board DirectorAQSE:APOLApollon Formularies plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AQSE:APOL

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
G
Generali
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
TITR
Telecom Italia
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network